Our commitment to improving patient outcomes inspires us to address global health disparities. We collaborate with partners outside the company to expand community education, increase health care provider outreach and break down barriers to care.
Our teams deepened their collaboration with nongovernmental organizations, nonprofits, health care advocates and providers to address health inequities in underrepresented populations.
women and people of color identified in health action plans to advance equitable care in underserved U.S. communities
donated to fund medical research, fellowships, education and charitable organizations globally
ELEGANCE drives critical clinical insights for underrepresented patient populations
Approximately 200 million people around the world are affected by peripheral artery disease, a common circulatory problem that disproportionately affects Black men and women. Clinical studies for the disease typically do not include the common patient populations affected by the disease.
As of 2022, Boston Scientific’s ELEGANCE registry is currently exceeding its goal to increase the representation of women and underrepresented minorities in clinical trials to better reflect the populations affected by peripheral artery disease. Current enrollment spans 46 global sites and includes 43% women and 47% underrepresented minorities.
“Increasing diversity in medical research is a critical step to ensure that everyone can benefit from treatments and therapies. Now is the time to eliminate disparities in health care — once and for all.”
– Michael R. Jaff, D.O., chief medical officer and vice president, clinical affairs, technology and intervention, Peripheral Interventions
Explore our progress
Learn more about our 2022 progress in working towards health equity.
Boston Scientific is proud to be recognized for our health care innovations that impact patients' lives.
All data as of December 31, 2022 unless otherwise noted.